Overview
Neonatal sepsis is a serious bloodstream infection that occurs in newborn infants, typically within the first weeks of life, when bacteria, and less often viruses or fungi, invade the blood and trigger a systemic inflammatory response. It is commonly divided into early-onset disease, acquired around the time of birth from the maternal genital tract, and late-onset disease, acquired from the environment or healthcare setting after birth. Premature and low-birth-weight infants are at particular risk because of their immature immune defences. Signs can be subtle and non-specific, including temperature instability, breathing difficulty, poor feeding, lethargy, and changes in heart rate, which makes early recognition and prompt treatment essential. Diagnosis relies on clinical assessment supported by blood cultures and laboratory markers, and the search for reliable early biomarkers remains an active area of investigation. Management centres on timely antimicrobial therapy, supportive care, and, increasingly, on judicious antibiotic use within neonatal units to limit unnecessary exposure and resistance. Within neonatology, research on neonatal sepsis spans diagnosis, antimicrobial stewardship in neonatal care, and outcomes in vulnerable newborns. This page gathers peer-reviewed, open-access research relevant to neonatal sepsis and newborn infection within the journal's scope.
Research published in this journal
7 peer-reviewed articles, ranked by relevance. Each links to its DOI.
How this research is being cited
The 7 articles above have been cited 55 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Jun 2026.
-
E. Njoga et al. · 2025 · One Health
-
2025 ·
-
2025 · Food Science & Nutrition
-
K. P. Kariyawasam et al. · 2025 · Food Science & Nutrition
-
2025 · Pteridines
-
2024 · BioMed Target Journal
-
2024 · Children
-
2024 · BMC Ophthalmology
A sample of recent works citing this journal's research on Neonatal Sepsis, linking to each citing work.